equity is 0.42 times. December 31, 2019 March 31, 2020 Change (THB million) (THB million) (THB million) % Cash and cash equivalents 3,591.6 3,543.1 (48.5) (1.4%) Total current assets 5,126.6 5,635.2 508.6
Operating Results of the Company in Q2/2020 Q2/18 Q2/19 1H/18 1H/19 Change +/(-) (THB million) YoY 1H Operating Revenue 312 144 (54%) 599 363 (39%) Gross Profit 201 79 (61%) 389 216 (44%) EBITDA 95 27 (72
take-home products. Executive Summary 2 Overall Operating Results of the Company in Q3/2020 Q3/19 Q3/20 9M/19 9M/20 Change +/(-) (THB million) YoY 9M Operating Revenue 312 198 (37%) 911 561 (38%) Gross
Baht 30-Sep-19 31-Dec-18 Total Assets 28,635 30,632 Total Liabilities 19,001 20,532 Total Equity (911) 172 Minority 10,545 9,928 Gr ou p HR C Gr ou p Management Discussion and Analysis Quarter 3 Ending
to generate additional income. 2018 is the Year of Change as all aspects of the operation are modified in order for the Company to achieve sustainable growth under sufficiency economy principles. The
ended 31 March 2018 and 2017 are as follows; Unit: THB million Q1-2018 Q1-2017 % Change 1. Revenue from sales and contract work 1.2 1.2 2.1% 1.1 Turnkey Total Solutions 1.2 1.2 2.1% 2. Revenue from
previous year were as highlighted below ; (Unit : Million Baht) Q1/2018 Q1/2017 % Change Sales and Service Income 467 461 1 Cost of sales and Services 384 339 13 Selling and Administrative Expenses 60 70 (14
in Q2/2017. (Unit: Thousand Baht) Revenues Gross Profit Selling Admin Net(loss) profit Q2/17 222,225 80,232 19,957 22,698 (293,091)*** Q2/18 221,202 78,238 21,637 19,916 35,335 Change -1,023 -1,994
higher than the last year quarter of THB 165 million due to the strengthen in THB as compared to US dollar. There would be the material change in Q3 for the Balance Sheet structure of which expecting to
, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Financial Position As at December 31 Change 2019 2018 MB MB MB % Total assets 525.87 195.47 330.40 169.03